- Country: Czech Republic
- Summary: Cytostatika 2024-Ii
- CZT Ref No: 98381135
- Deadline: 08 Apr 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CZK 16720000
- Notice Type: Tender
- Document Ref. No.: 140146-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the public order is the supply of medicinal products intended for the therapy of malignant diseases in the total expected volume of 262,960 individual doses of medicinal products.
Delivery of the subject of performance budou implemented on the basis of the results of the completed procurement procedure for a period of four years from the signing of the purchase contract.
Cytostatic agent containing the active substance ixazomib
P. o. form containing 4 mg of ixazomib per form unit, expected annual volume of 60 form units (doses); ATC L01XG03
Cytostatic agent containing ucnn substances trametinib
P. o. a form containing 2 mg of trametinib in a form unit, expected annual volume of 4,200 form units (doses); ATC L01EE01
Cytostatic containing the active substance ribociclib
P. o. form containing 200 mg of ribociclib per form unit, expected annual volume of 18,900 form units(dose); ATC J01EF02
Cytostatic agent containing the active substance encorafenib
P. o. form containing 75 mg of encorafenib in a form unit, expected annual volume of 10,920 form units (doses); ATC L01EC03
Cytostatic containing the active substance binimetinib
P. o. form containing 15 mg of binimetinib in the for unitwe, expected annual volume of 7,560 units of form (doses); ATC L01EE03
Cytostatic drug containing the active substance ruxolitinib
P. o. a form containing 20 mg of ruxolitinib in a form unit, expected annual volume of 2,800 form units (doses); ATC L01EJ01
Cytostatic drug containing the active substance ponatinib
P. o.f... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCytostatika 2024-Ii - Czech Tender
The UNIVERSITY HOSPITAL IN PILSEN, a Government sector organization in Czech Republic, has announced a new tender for Cytostatika 2024-Ii. This tender is published on CzechTenders under CZT Ref No: 98381135 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-04-08.
The estimated tender value is CZK 16720000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
